On 3/12/24, Sunrun Inc (NASDAQ: RUN) stock suffered a major decline of -10.9%, closing at $10.70. This decline was accompanied by normal trading volume. The stock has been weak relative to the market over the […]
For its fourth fiscal quarter (ending December 31), Archer-Daniels-Midland Co (NYSE: ADM) has reported a -41% decline in E.P.S. from $1.84 a year ago to $1.08 in the current quarter. This performance was $-0.35 short […]
BUSINESS Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers […]
What is the market’s view of ANI Pharmaceuticals’ future operating performance as reflected in the current price of $69? Over the next 6 years, ANI Pharmaceuticals shares will need to reach $116 to achieve average […]
BUSINESS El Pollo Loco Holdings, Inc., through its subsidiary, El Pollo Loco, Inc., develops, franchises, licenses, and operates quick-service restaurants under the El Pollo Loco name. As of May 04, 2022, the company operated 480 […]
Cryoport Inc (NASDAQ: CYRX) has reported a loss for its fourth fiscal quarter (ending December 31) of $-1.31 versus a loss $-0.24 for the same period a year ago. This result fell short of the […]
Ultralife Corp (NASDAQ: ULBI) stock suffered a major decline of -11.0% on 3/12/24. The shares closed at $8.71. Moreover, exceptionally high trading volume at 241% of normal accompanied the decline. The stock has been exceptionally […]
On 3/12/24, NN Inc (NASDAQ: NNBR) stock suffered a major decline of -17.9%, closing at $4.16. Moreover, trading volume in this decline was exceptionally high at 388% of normal. Relative to the market the stock […]
Recent extremely meaningful positive changes in investment behavior have benefitted NL Industries Inc. (NYSE: NL): positive upside/downside volume developed, the stock’s recent price rise disrupted its longer term downtrend, and its shorter term price trend […]
Integra LifeSciences Holdings Co (NASDAQ: IART) suffers from meaningful negative changes in fundamentals: significant quarterly sales deceleration occurred, the consensus estimate for December, 2024 decreased significantly, and the consensus estimate for December, 2025 decreased significantly. […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research